Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-28

Clinical Trial Update: Revive Toric RWE Study

View source ↗

Summary

A real-world evidence study nicknamed 'Revive Toric' for correcting astigmatism is listed as not yet recruiting, sponsored by Bausch & Lomb.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Revive Toric

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Astigmatism | Status: NOT_YET_RECRUITING